Tag Archives: Boston Scientific

Economic downturn bad for investment? Depends on who’s buying.

Typical exit strategies for medical technology companies who have succeeded in developing and commercializing their products include IPO, but  the prospects for this strategy have diminished in recent years.  With global financial markets in disarray as they wait breathlessly to see where and when the bottom will be, the prospects for entrance, let alone exit, [...]